Persistent High-Grade Fever in a Patient with EBV

Diagnostic Considerations

A patient with persistent high-grade fever 10 days after EBV diagnosis should be evaluated for chronic active EBV infection (CAEBV) or other EBV-associated complications such as hemophagocytic lymphohistiocytosis (HLH) 1, 2
Chronic Active EBV Infection (CAEBV) is characterized by persistent or recurrent infectious mononucleosis-like symptoms, unusual patterns of anti-EBV antibodies, and increased EBV genomes in affected tissues 1, 2
Hemophagocytic Lymphohistiocytosis (HLH) is an EBV-triggered hyperinflammatory syndrome with persistent fever, cytopenias, and extremely elevated ferritin levels (>1000 ng/mL) 3
Secondary bacterial infection can occur during recovery from primary EBV infection 4

Quantitative EBV PCR with viral loads of more than 10^2.5 copies/μg DNA in peripheral blood mononuclear cells suggests CAEBV 2
Cytokine analysis showing elevated inflammatory cytokines may indicate HLH or CAEBV 2, 3
Bone marrow examination may be necessary if HLH is suspected, to look for hemophagocytosis 3

For CAEBV, patients often have poor prognosis and may require aggressive immunomodulatory therapy 1, 2
For HLH, prompt recognition and treatment with immunosuppressive therapy, potentially including corticosteroids, is necessary 3

Persistent fever beyond 10 days after EBV diagnosis is not typical of uncomplicated primary EBV infection and warrants further investigation 1, 2
The combination of persistent fever, lymphadenopathy, and hepatosplenomegaly is particularly concerning for CAEBV 2
Assuming all EBV infections are self-limiting can be a pitfall, as persistent symptoms require thorough evaluation 1, 2
Overlooking HLH can be life-threatening, requiring prompt diagnosis and treatment 3
Failing to consider chronic active EBV can lead to delayed diagnosis of this rare but serious condition 1, 2

Chronic EBV infection can lead to serious complications including hemophagocytic lymphohistiocytosis (HLH) and lymphoproliferative disorders, characterized by persistent or recurrent infectious mononucleosis-like symptoms, unusual patterns of anti-EBV antibodies, and increased EBV genomes in affected tissues 5, 6, 7

Ferritin is a key diagnostic biomarker in EBV-associated conditions, particularly in systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still's disease (AOSD), with significantly elevated ferritin levels (>1000 ng/mL) commonly seen in EBV-triggered HLH 8, 5
Monitoring ferritin levels helps assess treatment response alongside sCD25, cell counts, and EBV DNA in EBV-associated HLH 5

In patients with unexplained chronic fatigue, lymphadenopathy, and autoimmune manifestations, testing for both EBV and ferritin levels is warranted, as the combination of chronic EBV infection, autoimmune markers, and abnormal ferritin levels should raise suspicion for EBV-associated autoimmune disease 6, 7, 8
Monitoring ferritin levels in patients with known chronic EBV infection can help detect developing autoimmune complications 5
Treatment of EBV-associated autoimmune conditions with low ferritin should focus on addressing the underlying EBV infection and managing specific autoimmune manifestations with appropriate immunomodulatory therapy 9
In severe cases of EBV-triggered autoimmune disease with refractory symptoms, more aggressive approaches including rituximab or even stem cell transplantation may be considered 5, 9

High IgG antibody titers against EBV VCA (≥1:640) and EA (≥1:160) are characteristic of Chronic Active EBV Infection (CAEBV), though these thresholds vary by laboratory 10, 11, 12, 13
The American Society of Hematology recommends considering CAEBV in patients with persistent or recurrent infectious mononucleosis-like symptoms, unusual antibody patterns, and increased EBV genomes in affected tissues 10, 11, 12
Patients with CAEBV often have IgA antibodies against VCA and/or EA, which is unusual in typical past infection 10, 11, 12

Antibody titers obtained by different laboratories are not comparable because immunofluorescence tests are subjective and depend on factors such as microscope quality and reagent sources 10, 11, 12
The American Society of Hematology notes that a "high" titer in one laboratory may not be equivalent to the same numerical value in another laboratory 10, 11

The American Society of Hematology states that patients with CAEBV can progress to T-cell or NK-cell malignant lymphomas, making early recognition critical in symptomatic patients 10, 11, 13
Some CAEBV patients develop oligoclonal or monoclonal lymphoproliferation, eventually resulting in T-cell or NK-cell malignant lymphomas 10, 11, 13

The American Journal of Hematology suggests that Chronic Active EBV Infection (CAEBV) is characterized by persistent or recurrent infectious mononucleosis-like symptoms lasting beyond the typical recovery period, including persistent or intermittent fever, lymphadenopathy, and/or hepatosplenomegaly lasting weeks to months 14
Patients with CAEBV may experience recurrent debilitating fatigue, sore throat, lymph node pain, headache, myalgia, and arthralgia, with high IgG antibody titers against EBV VCA and EA 14
Quantitative EBV PCR showing viral loads >10^2.5 copies/μg DNA in peripheral blood mononuclear cells is a diagnostic feature of CAEBV 14
The American Journal of Hematology recommends that patients with suspected CAEBV or persistent symptoms should undergo quantitative EBV PCR on peripheral blood mononuclear cells, and check EBV-specific antibody patterns 14
Cytokine analysis should be considered if Hemophagocytic Lymphohistiocytosis (HLH) is suspected, and bone marrow examination may be necessary if HLH is suspected 14
The American College of Hematology suggests that assuming all EBV infections are self-limiting can lead to delayed diagnosis of CAEBV or HLH, both of which require aggressive management and have poor prognosis if untreated 14